Sarah R Lieber1, Ruth-Ann Lee2, Yue Jiang3, Claire Reuter4, Randall Watkins3, Kristen Szempruch2, David A Gerber5, Chirag S Desai5, G Stephen DeCherney6, A Sidney Barritt1. 1. Division of Gastroenterology and Hepatology, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina. 2. Department of Pharmacy, UNC Health Care, Chapel Hill, North Carolina. 3. Department of Biostatistics, UNC Gillings School of Public Health, Chapel Hill, North Carolina. 4. Department of Specialty Pharmacy, Ochsner Medical Center, New Orleans, Louisiana. 5. Department of Surgery, UNC School of Medicine, Chapel Hill, North Carolina. 6. Division of Endocrinology, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
Abstract
BACKGROUND: Post-transplant diabetes mellitus (PTDM) is common after liver transplantation (LT). Yet, how PTDM relates to graft outcomes and survival needs elucidation as more individuals are transplanted for nonalcoholic fatty liver disease (NAFLD). METHODS: This single-center, retrospective study of adult LT recipients (2003-2016) identified PTDM incidence and associations with graft steatosis, rejection, and post-LT patient survival. Multivariable analysis investigated predictors of PTDM. Kaplan-Meier curves depicted patient survival 5 years post-LT. RESULTS: Among 415 adult LT recipients, 23% had pre-LT DM and 13% were transplanted for NAFLD. PTDM incidence was 34.7%, 46.9%, and 56.2% and overall survival was 90%, 80.9%, and 71.7% at 1, 3, and 5 years, respectively. Over a third of non-NAFLD patients developed PTDM. Half of PTDM cases developed by 6 months and 75% by 12 months. The PTDM group had more rejection episodes compared to no PTDM (31.9% vs 21.8%, P = 0.055), with trends toward worse patient survival 5 years post-LT (log-rank test P = 0.254). Age was the only significant predictor of PTDM. CONCLUSIONS: Post-transplant diabetes mellitus occurs rapidly in the post-LT period and is a significant problem for both NAFLD and non-NAFLD LT recipients. Age is a significant risk factor for PTDM. Outcomes trended toward increased rejection and worse survival among PTDM individuals, suggesting the benefit of early strategies targeting glucose control.
BACKGROUND: Post-transplant diabetes mellitus (PTDM) is common after liver transplantation (LT). Yet, how PTDM relates to graft outcomes and survival needs elucidation as more individuals are transplanted for nonalcoholic fatty liver disease (NAFLD). METHODS: This single-center, retrospective study of adult LT recipients (2003-2016) identified PTDM incidence and associations with graft steatosis, rejection, and post-LT patient survival. Multivariable analysis investigated predictors of PTDM. Kaplan-Meier curves depicted patient survival 5 years post-LT. RESULTS: Among 415 adult LT recipients, 23% had pre-LT DM and 13% were transplanted for NAFLD. PTDM incidence was 34.7%, 46.9%, and 56.2% and overall survival was 90%, 80.9%, and 71.7% at 1, 3, and 5 years, respectively. Over a third of non-NAFLD patients developed PTDM. Half of PTDM cases developed by 6 months and 75% by 12 months. The PTDM group had more rejection episodes compared to no PTDM (31.9% vs 21.8%, P = 0.055), with trends toward worse patient survival 5 years post-LT (log-rank test P = 0.254). Age was the only significant predictor of PTDM. CONCLUSIONS: Post-transplant diabetes mellitus occurs rapidly in the post-LT period and is a significant problem for both NAFLD and non-NAFLD LT recipients. Age is a significant risk factor for PTDM. Outcomes trended toward increased rejection and worse survival among PTDM individuals, suggesting the benefit of early strategies targeting glucose control.
Authors: Eric S Orman; Maria E Mayorga; Stephanie B Wheeler; Rachel M Townsley; Hector H Toro-Diaz; Paul H Hayashi; A Sidney Barritt Journal: Liver Transpl Date: 2015-08 Impact factor: 5.799
Authors: Jang I Moon; Ralph Barbeito; Raquel N Faradji; Jeffrey J Gaynor; Andreas G Tzakis Journal: Transplantation Date: 2006-12-27 Impact factor: 4.939
Authors: M S Cauble; R Gilroy; M F Sorrell; M E Mailliard; D L Sudan; J C Anderson; J L Wisecarver; S Balakrishnan; J L Larsen Journal: Transplantation Date: 2001-04-15 Impact factor: 4.939
Authors: Trevor J Wilke; Bradley A Fremming; Brittany A Brown; Nicholas W Markin; Cale A Kassel Journal: J Cardiothorac Vasc Anesth Date: 2021-02-06 Impact factor: 2.628
Authors: Diego García-Compeán; Emanuela Orsi; Ramesh Kumar; Felix Gundling; Tsutomu Nishida; Jesús Zacarías Villarreal-Pérez; Ángel N Del Cueto-Aguilera; José A González-González; Giuseppe Pugliese Journal: World J Gastroenterol Date: 2022-02-28 Impact factor: 5.742
Authors: Thomas Marjot; Gwilym J Webb; Alfred S Barritt; Andrew M Moon; Zania Stamataki; Vincent W Wong; Eleanor Barnes Journal: Nat Rev Gastroenterol Hepatol Date: 2021-03-10 Impact factor: 73.082
Authors: Yip Han Chin; Hon Qin Marcus Tan; Cheng Han Ng; Darren Jun Hao Tan; Snow Yunni Lin; Daniel Q Huang; Chin Meng Khoo; Mark Dhinesh Muthiah Journal: J Clin Med Date: 2021-03-03 Impact factor: 4.241